Barbora Nussbaumerová

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons et al. · The Lancet · 2021 · 305 citations · Full text

Public Health, Endocrinology, Genetics +13

Effects of blood pressure and lipid lowering on cognition

Jackie Bosch, Martin O’Donnell, Balakumar Swaminathan et al. · Neurology · 2019 · 82 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Chromium Supplementation Reduces Resting Heart Rate in Patients with Metabolic Syndrome and Impaired Glucose Tolerance

Barbora Nussbaumerová, Hana Rosolová, M. Křížek et al. · Biological Trace Element Research · 2017 · 33 citations

Medicine, Endocrinology, Nutritional Sciences +14

Cardio-metabolic risk prediction should be superior to cardiovascular risk assessment in primary prevention of cardiovascular diseases

Hana Rosolová, Barbora Nussbaumerová · The EPMA Journal · 2011 · 19 citations · Full text

Medicine, Cardiology, Preventive Medicine +17

Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

Amany Elshorbagy, Alexander R.M. Lyons, Antonio J. Vallejo‐Vaz et al. · The Lancet Diabetes & Endocrinology · 2024 · 13 citations · Full text

Medicine, Endocrinology, Internal Medicine +11